Cleared Traditional

K244008 - Spectral CT

K244008 is the FDA 510(k) clearance for Spectral CT by Philips Medical Systems Technologies , Ltd.. It is a Class 2 Radiology device (product code JAK) cleared through the Traditional 510(k) pathway after a 141-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2025
Decision
141d
Days
Class 2
Risk

K244008 is an FDA 510(k) clearance for the Spectral CT. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Philips Medical Systems Technologies , Ltd. (Haifa, IL). The FDA issued a Cleared decision on May 16, 2025 after a review of 141 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Philips Medical Systems Technologies , Ltd. devices

Submission Details

510(k) Number K244008 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 26, 2024
Decision Date May 16, 2025
Days to Decision 141 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d slower than avg
Panel avg: 107d · This submission: 141d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 589
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K244008.
CardIQ Suite
K243672 · GE Medical Systems SCS · Jun 2025
SCENARIA View Phase 5.0
K250370 · Fujifilm Corporation · May 2025
uCT ATLAS Astound with uWS-CT-Dual Energy Analysis
K243617 · Shanghai United Imaging Healthcare Co., Ltd. · May 2025
SpotLight / SpotLight Duo with Low Dose Lung Cancer Screening Option
K250650 · Arineta , Ltd. · Apr 2025
Vitrea CT VScore
K243240 · Canon Medical Informatics, Inc. · Apr 2025
BodyTom 64
K242811 · Neurologica Corporation, A Subsidiary of Samsung · Mar 2025